Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1984 Mar;68(3):192–195. doi: 10.1136/bjo.68.3.192

Pharmacokinetics of oral acyclovir (Zovirax) in the eye.

S O Hung, A Patterson, P J Rees
PMCID: PMC1040285  PMID: 6696872

Abstract

Patients due for cataract extraction received 5 doses of 400 mg acyclovir (Zovirax) orally during the 24 hours prior to surgery. Aqueous humour levels of acyclovir (mean 3.26 microM) were well above the normal ED50 range for herpes simplex virus type 1, and showed a significant correlation with plasma concentrations (mean 8.74 microM). There was also a correlation between the age of the patient and the concentration of acyclovir in the plasma. Oral acyclovir was well tolerated.

Full text

PDF
194

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blum M. R., Liao S. H., de Miranda P. Overview of acyclovir pharmacokinetic disposition in adults and children. Am J Med. 1982 Jul 20;73(1A):186–192. doi: 10.1016/0002-9343(82)90088-2. [DOI] [PubMed] [Google Scholar]
  2. Colin J., Tournoux A., Chastel C., Renard G. Kératite herpétique superficielle. Traitement comparatif en double insu par acycloriv et idoxuridine. Nouv Presse Med. 1981 Oct 10;10(36):2969-70, 2975. [PubMed] [Google Scholar]
  3. Collum L. M., Benedict-Smith A., Hillary I. B. Randomised double-blind trial of acyclovir and idoxuridine in dendritic corneal ulceration. Br J Ophthalmol. 1980 Oct;64(10):766–769. doi: 10.1136/bjo.64.10.766. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Coster D. J., Wilhelmus K. R., Michaud R., Jones B. R. A comparison of acyclovir and idoxuridine as treatment for ulcerative herpetic keratitis. Br J Ophthalmol. 1980 Oct;64(10):763–765. doi: 10.1136/bjo.64.10.763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Crumpacker C. S., Schnipper L. E., Zaia J. A., Levin M. J. Growth inhibition by acycloguanosine of herpesviruses isolated from human infections. Antimicrob Agents Chemother. 1979 May;15(5):642–645. doi: 10.1128/aac.15.5.642. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dawson C., Togni B., Moore T. E., Jr Structural changes in chronic herpetic keratitis. Studied by light and electron microscopy. Arch Ophthalmol. 1968 Jun;79(6):740–747. doi: 10.1001/archopht.1968.03850040742016. [DOI] [PubMed] [Google Scholar]
  7. De Clercq E., Descamps J., Verhelst G., Walker R. T., Jones A. S., Torrence P. F., Shugar D. Comparative efficacy of antiherpes drugs against different strains of herpes simplex virus. J Infect Dis. 1980 May;141(5):563–574. doi: 10.1093/infdis/141.5.563. [DOI] [PubMed] [Google Scholar]
  8. Elion G. B., Furman P. A., Fyfe J. A., de Miranda P., Beauchamp L., Schaeffer H. J. Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5716–5720. doi: 10.1073/pnas.74.12.5716. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Elion G. B. Mechanism of action and selectivity of acyclovir. Am J Med. 1982 Jul 20;73(1A):7–13. doi: 10.1016/0002-9343(82)90055-9. [DOI] [PubMed] [Google Scholar]
  10. Jones B. R., Coster D. J., Fison P. N., Thompson G. M., Cobo L. M., Falcon M. G. Efficacy of acycloguanosine (Wellcome 248U) against herpes-simplex corneal ulcers. Lancet. 1979 Feb 3;1(8110):243–244. doi: 10.1016/s0140-6736(79)90769-4. [DOI] [PubMed] [Google Scholar]
  11. Jones B. R., Patterson A., Rice N. S. Symposium on certain forms of infective kerato-uveitis or uveitis. I. An approach to the problem, and the technique of anterior chamber tap. Trans Ophthalmol Soc U K. 1969;88:235–242. [PubMed] [Google Scholar]
  12. Kaufman H. E., Kanai A., Ellison E. D. Herpetic iritis: demonstration of virus in the anterior chamber by fluorescent antibody techniques and electron microscopy. Am J Ophthalmol. 1971 Feb;71(2):465–469. doi: 10.1016/0002-9394(71)90119-x. [DOI] [PubMed] [Google Scholar]
  13. Klauber A., Ottovay E. Acyclovir and idoxiuridine treatment of herpes simplex keratitis--a double blind clinical study. Acta Ophthalmol (Copenh) 1982 Oct;60(5):838–844. doi: 10.1111/j.1755-3768.1982.tb06748.x. [DOI] [PubMed] [Google Scholar]
  14. Laibson P. R., Pavan-Langston D., Yeakley W. R., Lass J. Acyclovir and vidarabine for the treatment of herpes simplex keratitis. Am J Med. 1982 Jul 20;73(1A):281–285. doi: 10.1016/0002-9343(82)90106-1. [DOI] [PubMed] [Google Scholar]
  15. McGill J., Tormey P., Walker C. B. Comparative trial of acyclovir and adenine arabinoside in the treatment of herpes simplex corneal ulcers. Br J Ophthalmol. 1981 Sep;65(9):610–613. doi: 10.1136/bjo.65.9.610. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Poirier R. H., Kingham J. D., de Miranda P., Annel M. Intraocular antiviral penetration. Arch Ophthalmol. 1982 Dec;100(12):1964–1967. doi: 10.1001/archopht.1982.01030040944016. [DOI] [PubMed] [Google Scholar]
  17. Quinn R. P., de Miranda P., Gerald L., Good S. S. A sensitive radioimmunoassay for the antiviral agent BW248U [9-(2-hydroxyethoxymethyl)guanine]. Anal Biochem. 1979 Oct 1;98(2):319–328. doi: 10.1016/0003-2697(79)90148-9. [DOI] [PubMed] [Google Scholar]
  18. Schaeffer H. J., Beauchamp L., de Miranda P., Elion G. B., Bauer D. J., Collins P. 9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature. 1978 Apr 13;272(5654):583–585. doi: 10.1038/272583a0. [DOI] [PubMed] [Google Scholar]
  19. Shimeld C., Tullo A. B., Easty D. L., Thomsitt J. Isolation of herpes simplex virus from the cornea in chronic stromal keratitis. Br J Ophthalmol. 1982 Oct;66(10):643–647. doi: 10.1136/bjo.66.10.643. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Whitley R. J., Blum M. R., Barton N., de Miranda P. Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals. Am J Med. 1982 Jul 20;73(1A):165–171. doi: 10.1016/0002-9343(82)90084-5. [DOI] [PubMed] [Google Scholar]
  21. Witmer R., Iwamoto T. Electron microscope observation of herpes-like particles in the iris. Arch Ophthalmol. 1968 Mar;79(3):331–337. doi: 10.1001/archopht.1968.03850040333019. [DOI] [PubMed] [Google Scholar]
  22. la Lau C., Oosterhuis J. A., Versteeg J., van Rij G., Renardel de Lavalette J. G., Craandijk A., Lamers W. P., Lamers W. P. Acyclovir and trifluorothymidine in herpetic keratitis: a multicentre trial. Br J Ophthalmol. 1982 Aug;66(8):506–508. doi: 10.1136/bjo.66.8.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. van der Meer J. W., Versteeg J. Acyclovir in severe herpes virus infections. Am J Med. 1982 Jul 20;73(1A):271–274. doi: 10.1016/0002-9343(82)90104-8. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES